Young Discusses New Requirements On Federally Funded Duke University Medical Researchers
March 26, 2018
Durham Herald Sun
Senior Counsel Torrey Young was quoted in a Durham Herald Sun article, “The feds are keeping a closer eye on Duke research grants. Why?” about the imposition of new National Institutes of Health requirements on university-based medical research in response to concerns about Duke’s handling of several recent research misconduct cases.
Young said the significance of the move is that the NIH, which funds tens of millions of dollars’ worth of medical research at Duke each year, seems worried about more than just a few individual bad actors.
“It’s a call for making sure the entire process is being overseen by the university, which is the ultimate recipient of the grant funds,” she said. “Historically, a lot of research misconduct cases have focused on the individual investigator. This is drawing more attention to institutional processes.”
Young said the significance of the move is that the NIH, which funds tens of millions of dollars’ worth of medical research at Duke each year, seems worried about more than just a few individual bad actors.
“It’s a call for making sure the entire process is being overseen by the university, which is the ultimate recipient of the grant funds,” she said. “Historically, a lot of research misconduct cases have focused on the individual investigator. This is drawing more attention to institutional processes.”
Related News
June 10, 2025
In the News
Lynn Gandhi Sheds Light on Supreme Court Tax Ruling
Foley partner Lynn Gandhi commented in the Bloomberg Tax article "High Court’s Catholic Charities Case to Go Beyond Unemployment," sharing insight on the implications of the recent Supreme Court ruling in a tax case.
June 10, 2025
In the News
James McFall Joins Iconic Athletes and Leaders in Launch of Stanford Football Alumni United
Foley & Lardner LLP is proud to announce that partner James Carlos McFall is a founding member of Stanford Football Alumni United (SFAU), a newly formed coalition of former players and leaders committed to supporting Stanford Football’s continued growth and national competitiveness.
June 6, 2025
In the News
David Rosen Comments on FDA, Compounder Conflict Over Drug Shortages
Foley & Lardner LLP partner David Rosen highlighted the U.S. Food and Drug Administration's drug shortage list in the BioSpace article, "Post-Chevron Legal Battles: Three Key Cases to Watch."